1102. Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.
作者: Nicholas A Turner.;Toshimitsu Hamasaki.;Sarah B Doernberg.;Thomas P Lodise.;Heather A King.;Varduhi Ghazaryan.;Sara E Cosgrove.;Timothy C Jenkins.;Catherine Liu.;Shrabani Sharma.;Smitha Zaharoff.;Lana Wahid.;Valerie J Renard.;Paul Cook.;Issam Raad.;Ray Hachem.;Anne-Marie Chaftari.;Matthew Sims.;Carmen DeMarco.;Loren G Miller.;Matthew W McCarthy.;Caryn G Morse.;Chris Lucasti.;Graeme N Forrest.;Kartikeya Cherabuddi.;Christopher Polk.;Tasaduq Fazili.;Mark E Rupp.;George R Thompson.;Kami Kim.;Luke Strnad.;Amanda E Schnee.;James A McKinnell.;Mayur Ramesh.;Fernanda P Silveira.;Todd P McCarty.;Todd C Lee.;Emily G McDonald.;Kristopher Paolino.;Katie Wiegand.;Alison Wall.;Todd Riccobene.;Rinal Patel.;Urania Rappo.;Scott Evans.;Henry F Chambers.;Vance G Fowler.;Thomas L Holland.; .
来源: JAMA. 2025年
Dalbavancin is a long-acting intravenous lipoglycopeptide that may be effective for treatment of complicated Staphylococcus aureus bacteremia without requiring long-term intravenous access.
1106. In Utero Embolization for Fetal Vein of Galen Malformation.
作者: Darren B Orbach.;Alireza A Shamshirsaz.;Louise Wilkins-Haug.;Stephanie Guseh.;Eyal Krispin.;Wayne Tworetzky.;Brianna O'Leary.;Anna M Larson.;Shivani D Rangwala.;Soliman Oushy.;Alfred P See.
来源: JAMA. 2025年334卷10期878-885页
Vein of Galen malformation (VOGM) is the most common congenital cerebrovascular anomaly. Fetuses with VOGM and wide mediolateral falcine sinus diameters are at high risk for mortality, brain injury, and neurodevelopmental delay. In utero embolization may improve survival and outcomes.
|